A nanobody is a single domain antibody; it can be used to label or purify target proteins in biomedical research, and in immunohistochemistry during clinical diagnosis. The market size for breast cancer diagnosis is up to 200 million CNY. This project will lead to a nanobody R&D platform and realize its commercialization in batches.
?Light-weight, hydrophilic, thermal/pH stable, long shelf life with stable performance
?Simple structure, easy to synthesize, low cost
?Flexible chemical characteristics, strong binding affinity to antigens, and high sensitivity in assays